Intro

This chapter delves into 23andMe's groundbreaking method of providing consumers with direct access to their health data, bypassing traditional medical channels. The discussion also covers the company's stock performance post-IPO and the broader implications of genetic testing in personalized medicine.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Get the app